The Rise of “Designer Babies”: Is Genetic Selection Heading Mainstream?
(Image: Entrepreneur Kian Sadeghi stands under advertising banner in the Broadway-Lafayette subway station in Manhattan, part of a campaign called ”Have Your Best Baby.” – COURTESY OF THE AUTHOR)
For decades, the concept of selecting a child’s traits – height, intelligence, even eye colour – existed firmly in the realm of science fiction. Today, fueled by rapid advancements in reproductive technology and a burgeoning market, that future is rapidly approaching. A recent advertising campaign in the New York City subway,spearheaded by the company Nucleus,has thrust the debate surrounding preimplantation genetic testing (PGT) for polygenic traits into the spotlight,sparking both excitement and ethical concerns. But is this simply a logical progression of reproductive choice, or are we on a slippery slope towards a genetically stratified society?
This article delves into the world of genetic embryo selection, exploring the science behind it, the companies driving its adoption, the ethical dilemmas it presents, and what it all means for the future of humanity.
Understanding Preimplantation Genetic Testing (PGT) and Polygenic Scores
Traditionally, PGT has been used to screen embryos for single-gene disorders like cystic fibrosis or Huntington’s disease. However, a new frontier has emerged: PGT for polygenic traits – characteristics influenced by many genes acting together, such as height, intelligence, and predisposition to certain diseases.
This is where “polygenic scores” come in. These scores, calculated by analyzing an individual’s genome, attempt to predict their likelihood of developing a trait. Companies like Nucleus and orchid are now offering PGT based on these scores, allowing prospective parents to select embryos with a higher predicted score for desired traits.
How does it work?
- IVF Process: The process begins with in vitro fertilization (IVF), where eggs are retrieved and fertilized with sperm in a laboratory.
- Embryo Biopsy: A few cells are removed from each embryo (a process called a trophectoderm biopsy) without harming it.
- Genetic Analysis: These cells are analyzed to determine the embryo’s polygenic score for specific traits.
- Embryo Selection: Parents, guided by their preferences and the genetic data, select the embryo(s) they wish to implant.
While the technology is impressive, it’s crucial to understand its limitations. Polygenic scores are not deterministic. They provide probabilities, not guarantees. A high score for intelligence doesn’t ensure a child will be a genius, and a low score doesn’t condemn them to underachievement.
The Players: Nucleus, Orchid, and the Venture Capital Behind Them
The “Have Your Best Baby” campaign, with its provocative subway ads, is the brainchild of Kian Sadeghi, founder of nucleus. The campaign’s goal, as Sadeghi openly admits, is to ”normalize” the idea of genetic selection.
Nucleus isn’t operating in a vacuum. Other companies, like Orchid, are also vying for a piece of this emerging market. Orchid, founded by Noor Siddiqui, takes a slightly different approach, focusing on providing the genetic testing services to IVF clinics, rather than directly marketing to consumers.
Both companies have attracted notable venture capital funding.nucleus received seed funding from Founders Fund, a firm known for its willingness to invest in disruptive - and often controversial - technologies.this backing signals a belief in the market potential of genetic embryo selection, despite the ethical concerns.
As Siddiqui pointed out in a recent industry event, consumer demand could pressure doctors to offer these tests, even if they have reservations. This dynamic mirrors the early days of ride-sharing services like Uber,which bypassed regulations by capitalizing on consumer desire for convenience.
The Ethical Minefield: Concerns and criticisms
The prospect of selecting embryos based on predicted traits raises a host of ethical questions:
* Equity and Access: These technologies are expensive, potentially exacerbating existing inequalities. Will genetic selection become a privilege reserved for the wealthy, creating a “genetic divide”?
* Defining “Desirable” Traits: Who decides which traits are worth selecting for? Focusing on traits like height and IQ could reinforce societal biases and devalue diversity.
* Unrealistic Expectations: Parents may place undue pressure on children to live up to their predicted genetic potential, leading to disappointment and psychological harm.
* the ”designer Baby” Concern: The fear of a future where children are engineered to meet parental specifications,potentially diminishing their autonomy and individuality.
* **Reliability of
Keep reading